Ledger.Open graph →
SEC Form D · filed June 9, 2021

Kojin Therapeutics, Inc

Offering
$60.2M
Sold
$30.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Amir Nashat, Ph.D · Boston, MAExec · DirectorThomas J. Cahill · Boston, MADirectorNagesh J. Mahanthappa, Ph.D · Boston, MADirectorSusan Langer · Boston, MAExecLuba J. Greenwood · Boston, MADirectorNagesh J. Mahanthappa, Ph.D · Boston, MADirectorAmir Nashat, Ph.D · Boston, MAExec · DirectorSusan Langer · Boston, MAExecLuba J. Greenwood · Boston, MADirectorThomas J. Cahill · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗